InMode (INMD) Stock Forecast, Price Target & Predictions
INMD Stock Forecast
InMode stock forecast is as follows: an average price target of $27.50 (represents a 48.73% upside from INMD’s last price of $18.49) and a rating consensus of 'Hold', based on 6 wall street analysts offering a 1-year stock forecast.
INMD Price Target
The average price target for InMode (INMD) is $27.50 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $58.00 to $16.00. This represents a potential 48.73% upside from INMD's last price of $18.49.
INMD Analyst Ratings
According to 6 Wall Street analysts, InMode's rating consensus is 'Hold'. The analyst rating breakdown for INMD stock is 0 'Strong Buy' (0.00%), 2 'Buy' (33.33%), 3 'Hold' (50.00%), 1 'Sell' (16.67%), and 0 'Strong Sell' (0.00%).
InMode Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 16, 2024 | Sam Elber | BTIG | $25.00 | $16.88 | 48.10% | 35.21% |
| Oct 12, 2024 | Matt Miksic | Barclays | $27.00 | $16.50 | 63.64% | 46.02% |
| Jul 23, 2024 | Matthew Taylor | Jefferies | $19.00 | $17.75 | 7.04% | 2.76% |
| Jul 12, 2024 | Caitlin Cronin | Canaccord Genuity | $16.00 | $16.82 | -4.88% | -13.47% |
| May 03, 2024 | Danielle Antalffy | UBS | $20.00 | $17.36 | 15.21% | 8.17% |
| Oct 13, 2023 | Caitlin Cronin | Canaccord Genuity | $22.00 | $20.75 | 6.02% | 18.98% |
| Dec 21, 2022 | - | Barclays | $44.00 | $35.22 | 24.93% | 137.97% |
| May 03, 2022 | - | Needham | $58.00 | $25.61 | 126.47% | 213.68% |
| Feb 11, 2022 | Matthew Taylor | UBS | $90.00 | $47.01 | 91.45% | 386.75% |
The latest InMode stock forecast, released on Oct 16, 2024 by Sam Elber from BTIG, set a price target of $25.00, which represents a 48.10% increase from the stock price at the time of the forecast ($16.88), and a 35.21% increase from INMD last price ($18.49).
InMode Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 5 |
| Avg Price Target | - | $26.00 | $21.40 |
| Last Closing Price | $18.49 | $18.49 | $18.49 |
| Upside/Downside | -100.00% | 40.62% | 15.74% |
In the current month, the average price target of InMode stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to InMode's last price of $18.49. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 16, 2024 | BTIG | - | Buy | Initialise |
| Oct 12, 2024 | Barclays | Overweight | Overweight | Hold |
| Oct 01, 2024 | Canaccord Genuity | Hold | Hold | Hold |
| Jul 23, 2024 | Jefferies | - | Hold | Downgrade |
| May 03, 2024 | UBS | Neutral | Neutral | Hold |
| Oct 13, 2023 | Canaccord Genuity | Buy | Hold | Downgrade |
| Feb 17, 2023 | Needham | Buy | Negative | Downgrade |
| Dec 21, 2022 | Barclays | - | Overweight | Initialise |
| Jun 30, 2022 | Canaccord Genuity | Buy | Buy | Hold |
| May 03, 2022 | Needham | Buy | Buy | Hold |
InMode's last stock rating was published by BTIG on Oct 16, 2024. The company Initialise its INMD rating from "null" to "Buy".
InMode Financial Forecast
InMode Revenue Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $121.23M | $113.55M | $85.92M | $110.54M | $94.18M | $87.33M | $65.52M | $75.19M | $59.71M | $30.77M | $40.44M | $47.00M | $40.01M |
| Avg Forecast | $131.17M | $121.95M | $107.77M | $96.38M | $121.21M | $112.42M | $100.70M | $91.35M | $114.22M | $126.52M | $104.81M | $91.41M | $124.77M | $131.26M | $132.55M | $101.44M | $129.69M | $113.52M | $103.15M | $80.23M | $104.98M | $89.38M | $76.82M | $56.20M | $70.76M | $52.60M | $20.22M | $38.96M | $42.48M | $35.74M |
| High Forecast | $143.46M | $133.37M | $117.87M | $105.40M | $132.56M | $122.95M | $110.14M | $99.80M | $124.92M | $130.74M | $104.81M | $91.43M | $136.46M | $137.95M | $144.96M | $110.94M | $141.84M | $113.52M | $103.15M | $80.23M | $104.98M | $89.38M | $76.82M | $56.20M | $70.76M | $52.60M | $20.22M | $38.96M | $42.48M | $35.74M |
| Low Forecast | $125.14M | $116.34M | $102.81M | $91.94M | $115.63M | $107.24M | $96.07M | $82.04M | $108.96M | $122.30M | $104.81M | $91.39M | $119.03M | $122.07M | $126.45M | $96.77M | $123.72M | $113.52M | $103.15M | $80.23M | $104.98M | $89.38M | $76.82M | $56.20M | $70.76M | $52.60M | $20.22M | $38.96M | $42.48M | $35.74M |
| # Analysts | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 1 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 1.10% | 1.07% | 1.05% | 1.05% | 1.14% | 1.17% | 1.06% | 1.14% | 1.52% | 1.04% | 1.11% | 1.12% |
InMode's average Quarter revenue forecast for Jan 23 based on 3 analysts is $129.69M, with a low forecast of $123.72M, and a high forecast of $141.84M. INMD's average Quarter revenue forecast represents a 6.98% increase compared to the company's last Quarter revenue of $121.23M (Sep 22).
InMode EBITDA Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 1 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $53.91M | $49.36M | $35.15M | $54.53M | $45.15M | $42.52M | $26.87M | $38.05M | $25.01M | $9.49M | $7.41M | $20.45M | $17.01M |
| Avg Forecast | $53.64M | $49.86M | $44.07M | $39.41M | $49.56M | $45.97M | $41.18M | $37.35M | $46.70M | $51.73M | $42.85M | $29.42M | $51.02M | $53.67M | $54.20M | $31.47M | $26.27M | $46.42M | $42.17M | $33.66M | $42.93M | $36.55M | $31.41M | $18.73M | $28.93M | $21.51M | $8.27M | $7.27M | $17.37M | $9.92M |
| High Forecast | $58.66M | $54.53M | $48.19M | $43.10M | $54.20M | $50.27M | $45.03M | $40.80M | $51.08M | $53.46M | $42.85M | $35.31M | $55.80M | $56.41M | $59.27M | $37.76M | $31.53M | $46.42M | $42.17M | $40.39M | $42.93M | $36.55M | $31.41M | $22.47M | $28.93M | $21.51M | $8.27M | $8.73M | $17.37M | $11.90M |
| Low Forecast | $51.17M | $47.57M | $42.04M | $37.59M | $47.28M | $43.85M | $39.28M | $33.54M | $44.55M | $50.01M | $42.85M | $23.54M | $48.67M | $49.91M | $51.70M | $25.17M | $21.02M | $46.42M | $42.17M | $26.92M | $42.93M | $36.55M | $31.41M | $14.98M | $28.93M | $21.51M | $8.27M | $5.82M | $17.37M | $7.93M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.16% | 1.17% | 1.04% | 1.27% | 1.24% | 1.35% | 1.43% | 1.32% | 1.16% | 1.15% | 1.02% | 1.18% | 1.71% |
3 analysts predict INMD's average Quarter EBITDA for Jan 23 to be $26.27M, with a high of $31.53M and a low of $21.02M. This is -51.27% lower than InMode's previous annual EBITDA (Sep 22) of $53.91M.
InMode Net Income Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 1 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $48.79M | $44.05M | $30.98M | $52.69M | $44.72M | $40.92M | $26.64M | $36.11M | $23.89M | $8.59M | $6.55M | $19.04M | $16.19M |
| Avg Forecast | $53.27M | $49.72M | $44.58M | $38.89M | $47.48M | $43.92M | $39.82M | $35.93M | $46.06M | $44.51M | $30.03M | $25.65M | $51.59M | $50.31M | $51.12M | $27.44M | $25.77M | $50.25M | $44.06M | $29.34M | $49.18M | $42.91M | $37.17M | $18.60M | $28.96M | $20.54M | $-2.66M | $7.02M | $16.18M | $9.71M |
| High Forecast | $59.75M | $55.77M | $50.01M | $43.62M | $53.26M | $49.26M | $44.67M | $37.70M | $51.66M | $49.93M | $30.04M | $30.78M | $57.87M | $52.67M | $57.34M | $32.92M | $30.92M | $50.25M | $44.06M | $35.21M | $49.18M | $42.91M | $37.17M | $22.32M | $28.96M | $20.54M | $-2.66M | $8.42M | $16.18M | $11.65M |
| Low Forecast | $50.08M | $46.74M | $41.92M | $36.56M | $44.64M | $41.29M | $37.44M | $34.34M | $43.30M | $41.84M | $30.02M | $20.52M | $48.50M | $47.17M | $48.06M | $21.95M | $20.62M | $50.25M | $44.06M | $23.48M | $49.18M | $42.91M | $37.17M | $14.88M | $28.96M | $20.54M | $-2.66M | $5.61M | $16.18M | $7.77M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.97% | 1.00% | 1.06% | 1.07% | 1.04% | 1.10% | 1.43% | 1.25% | 1.16% | -3.22% | 0.93% | 1.18% | 1.67% |
InMode's average Quarter net income forecast for Jan 23 is $25.77M, with a range of $20.62M to $30.92M. INMD's average Quarter net income forecast represents a -47.18% decrease compared to the company's last Quarter net income of $48.79M (Sep 22).
InMode SG&A Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 1 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $45.56M | $42.22M | $33.33M | $37.81M | $32.97M | $30.61M | $26.37M | $26.91M | $25.07M | $16.15M | $24.82M | $21.39M | $17.65M |
| Avg Forecast | $53.72M | $49.94M | $44.13M | $39.47M | $49.64M | $46.04M | $41.24M | $37.41M | $46.77M | $51.81M | $42.92M | $27.60M | $51.10M | $53.75M | $54.28M | $29.52M | $19.20M | $46.49M | $42.24M | $31.57M | $42.99M | $36.60M | $31.46M | $18.41M | $28.98M | $21.54M | $8.28M | $27.08M | $17.40M | $10.59M |
| High Forecast | $58.75M | $54.62M | $48.27M | $43.16M | $54.29M | $50.35M | $45.10M | $40.87M | $51.16M | $53.54M | $42.92M | $33.12M | $55.88M | $56.49M | $59.36M | $35.42M | $23.04M | $46.49M | $42.24M | $37.89M | $42.99M | $36.60M | $31.46M | $22.09M | $28.98M | $21.54M | $8.28M | $32.49M | $17.40M | $12.71M |
| Low Forecast | $51.25M | $47.64M | $42.10M | $37.65M | $47.35M | $43.92M | $39.34M | $33.60M | $44.62M | $50.08M | $42.92M | $22.08M | $48.74M | $49.99M | $51.78M | $23.62M | $15.36M | $46.49M | $42.24M | $25.26M | $42.99M | $36.60M | $31.46M | $14.73M | $28.98M | $21.54M | $8.28M | $21.66M | $17.40M | $8.47M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.98% | 1.00% | 1.06% | 0.88% | 0.90% | 0.97% | 1.43% | 0.93% | 1.16% | 1.95% | 0.92% | 1.23% | 1.67% |
InMode's average Quarter SG&A projection for Jan 23 is $19.20M, based on 3 Wall Street analysts, with a range of $15.36M to $23.04M. The forecast indicates a -57.85% fall compared to INMD last annual SG&A of $45.56M (Sep 22).
InMode EPS Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 1 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.59 | $0.54 | $0.37 | $0.63 | $0.54 | $0.50 | $0.34 | $0.48 | $0.33 | $0.12 | $0.10 | $0.29 | $0.27 |
| Avg Forecast | $0.68 | $0.63 | $0.57 | $0.50 | $0.60 | $0.56 | $0.51 | $0.46 | $0.59 | $0.57 | $0.38 | $0.43 | $0.66 | $0.64 | $0.65 | $0.47 | $0.67 | $0.58 | $0.51 | $0.36 | $0.57 | $0.50 | $0.43 | $0.27 | $0.34 | $0.24 | $-0.03 | $0.16 | $0.19 | $0.15 |
| High Forecast | $0.76 | $0.71 | $0.64 | $0.56 | $0.68 | $0.63 | $0.57 | $0.48 | $0.66 | $0.64 | $0.38 | $0.44 | $0.74 | $0.67 | $0.73 | $0.52 | $0.75 | $0.58 | $0.51 | $0.36 | $0.57 | $0.50 | $0.43 | $0.27 | $0.34 | $0.24 | $-0.03 | $0.16 | $0.19 | $0.15 |
| Low Forecast | $0.64 | $0.60 | $0.53 | $0.47 | $0.57 | $0.53 | $0.48 | $0.44 | $0.55 | $0.53 | $0.38 | $0.43 | $0.62 | $0.60 | $0.61 | $0.44 | $0.63 | $0.58 | $0.51 | $0.36 | $0.57 | $0.50 | $0.43 | $0.27 | $0.34 | $0.24 | $-0.03 | $0.16 | $0.19 | $0.15 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.05% | 1.02% | 1.10% | 1.08% | 1.16% | 1.27% | 1.42% | 1.36% | -3.87% | 0.58% | 1.54% | 1.78% |
According to 3 Wall Street analysts, InMode's projected average Quarter EPS for Jan 23 is $0.67, with a low estimate of $0.63 and a high estimate of $0.75. This represents a 12.96% increase compared to INMD previous annual EPS of $0.59 (Sep 22).
InMode Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| TNDM | Tandem Diabetes Care | $30.74 | $79.05 | 157.16% | Buy |
| ALGN | Align | $228.21 | $421.00 | 84.48% | Buy |
| TMDX | TransMedics Group | $79.34 | $126.75 | 59.76% | Buy |
| INMD | InMode | $18.49 | $27.50 | 48.73% | Hold |
| NARI | Inari Medical | $49.75 | $66.11 | 32.88% | Buy |
| INSP | Inspire Medical Systems | $186.19 | $239.55 | 28.66% | Buy |
| MDT | Medtronic | $84.74 | $107.91 | 27.34% | Hold |
| EW | Edwards Lifesciences | $70.38 | $88.04 | 25.09% | Buy |
| ZBH | Zimmer Biomet | $108.40 | $133.78 | 23.41% | Hold |
| DXCM | DexCom | $74.46 | $81.36 | 9.27% | Buy |
| ABT | Abbott Laboratories | $117.26 | $126.45 | 7.84% | Buy |
| PODD | Insulet | $262.00 | $274.00 | 4.58% | Buy |
| SYK | Stryker | $390.14 | $317.96 | -18.50% | Buy |
| SWAV | ShockWave Medical | $334.75 | $258.17 | -22.88% | Hold |